GHK-Cu is not currently approved by the Therapeutic Goods Administration (TGA) for therapeutic use in Australia
They exist on both semaglutide and tirzepatide
What the pricing does not include MEDVi does not offer insurance billing
(silymarin) in the treatment of type II diabetes: a randomized, double-blind, placebo-controlled, clinical trial
Combining Sermorelin with GLP-1 or GIP agonists offers a comprehensive strategy that addresses both sides of the weight loss equation: Benefits of This Dual-Therapy Approach: Avoids the skinny fat effect by preserving muscle Maintains metabolic rate even as body weight decreases Supports better strength, tone, and energy throughout the process Enhances sustainability of results post-treatment Real Results with Clinical Oversight This strategy works best when paired with: Adequate protein intake Resistance-based exercise Regular in-clinic follow-up and lab monitoring Personalized dosing protocols At NeuVitality Buford , our licensed medical team builds customized plans to optimize outcomes and minimize side effects
Third: glutathione reduces oxidative stress, which could mitigate GLP-1 side effects like nausea or fatigue